ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2429

mHealth-enabled Peer Coaching for Fatigue in Systemic Lupus Erythematosus (SLE): Preliminary Results from the Restore Energy, Activity Can Help (REACH) Pilot Randomized Controlled Trial

Shanthini Kasturi1, Erin Morrissey1, Anna Deck2, Nina Gulati2, Zoe Gilbard2, Kiran Singh1, Monique Gore-Massy3, Faye Chiu4, Priscilla Calvache5, Jillian Rose-Smith5, Andre Ogura6, Lucas Ogura Dantas6, Wambui Machua7, Julia Nguyen8, Lisa Mandl5, Hocine Tighiouart1, Ludovic Trinquart2, Iris Navarro-Millan9 and Sara Folta10, 1Tufts Medical Center, Boston, MA, 2Tufts University School of Medicine, Boston, MA, 3N/A, West Orange, NJ, 4N/A, New York, NY, 5Hospital for Special Surgery, New York, NY, 6Ambulomics, Arlington, MA, 7Piedmont Healthcare, Atlanta, GA, 8Hospital for Special Surgery, New York, 9Weill Cornell Medicine, Hospital for Special Surgery, Poughkeepsie, NY, 10Tufts Friedman School of Nutrition, Boston, MA

Meeting: ACR Convergence 2025

Keywords: Fatigue, physical activity, quality of life, Randomized Trial, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Fatigue is a highly prevalent and debilitating symptom affecting up to 90% of individuals living with systemic lupus erythematosus (SLE). Despite its significant impact, fatigue remains difficult to treat due to its complex, multifactorial origin, including behavioral and psychosocial factors. While physical activity interventions have shown promise in reducing SLE-related fatigue, they often fail to address these multiple factors and have been limited by their in-person format. The aim of this study is to evaluate the feasibility and preliminary efficacy of the Restore Energy, Activity Can Help (REACH) mobile health (mHealth)-enabled peer coaching intervention for fatigue in SLE.

Methods: Individuals meeting 2019 ACR SLE classification criteria were enrolled in this open-label pilot randomized controlled trial. Participants were randomized to the REACH mHealth-enabled peer coaching intervention or the REACH mHealth application (app)-only control arm. Participants in the intervention arm were paired with trained coaches with lived SLE experience who supported participants through a 12-week structured program promoting physical activity facilitated by the REACH app. Program feasibility was assessed via enrollment and adherence rates, and acceptability was evaluated with participant net promoter scores. Preliminary efficacy of the intervention was examined by comparing Fatigue Severity Scale (FSS) scores between arms at 12 weeks using ANCOVA. All participants were interviewed for feedback at program completion.

Results: Thirty-three of 43 eligible individuals screened enrolled (76.7% enrollment rate), with a mean baseline FSS score of 5.6 (SD 0.8) (Table 1). In the 29 participants in whom data collection has been completed to date, 26 finished the program (completion rate 89.7%) (Table 2). Program adherence rates were high, especially in the peer coaching arm, in which mean completion rates of educational modules, weekly check-ins and patient-reported outcome surveys were over 90% (Table 2). At 12 weeks, mean FSS scores were 0.8 (95% CI 0.2 to 1.5) lower in the coaching arm than the app-only arm, and a clinically meaningful improvement of ³ 0.6 was achieved in 75% of participants in the coaching arm vs. 40% in the app arm. Likelihood to recommend the program and its individual components were higher in the coaching arm than the app-only arm (Table 2). Participants in both arms shared that the program was impactful, citing improvements in self-efficacy and increased self-awareness and self-regulation facilitated by the accountability and motivation provided by both the peer coach and the REACH app. (Table 3).

Conclusion: The REACH peer coaching intervention was feasible and demonstrated promising preliminary efficacy for reducing fatigue in SLE. Participants in the coaching arm showed greater improvement in fatigue, with a higher proportion achieving a clinically meaningful benefit than in the app-only arm. Participant engagement and satisfaction were high. These findings support the potential of mHealth-enabled peer coaching to address behavioral and psychosocial drivers of fatigue in SLE and warrant further evaluation in larger trials.

Supporting image 1Table 1. Sociodemographic and clinical characteristics of participants

Supporting image 2Table 2. REACH program adherence rates and acceptability ratings

Supporting image 3Table 3. Impact of REACH program: thematic analysis of participant interview feedback


Disclosures: S. Kasturi: GlaxoSmithKlein(GSK), 1; E. Morrissey: None; A. Deck: None; N. Gulati: None; Z. Gilbard: None; K. Singh: None; M. Gore-Massy: Bristol-Myers Squibb(BMS), 2, 6, GlaxoSmithKlein(GSK), 1, Janssen, 1, 2, 6; F. Chiu: None; P. Calvache: None; J. Rose-Smith: None; A. Ogura: Ambulomics, 3; L. Ogura Dantas: Ambulomics, 3; W. Machua: Aurinia, 2, BMS Foundation, 5, Genentech, 2, GlaxoSmithKlein(GSK), 2, 6, Janssen, 1; J. Nguyen: None; L. Mandl: ACP, 12, Associate Editor Annals of Internal Medicine, Wolters, 9; H. Tighiouart: None; L. Trinquart: None; I. Navarro-Millan: None; S. Folta: None.

To cite this abstract in AMA style:

Kasturi S, Morrissey E, Deck A, Gulati N, Gilbard Z, Singh K, Gore-Massy M, Chiu F, Calvache P, Rose-Smith J, Ogura A, Ogura Dantas L, Machua W, Nguyen J, Mandl L, Tighiouart H, Trinquart L, Navarro-Millan I, Folta S. mHealth-enabled Peer Coaching for Fatigue in Systemic Lupus Erythematosus (SLE): Preliminary Results from the Restore Energy, Activity Can Help (REACH) Pilot Randomized Controlled Trial [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/mhealth-enabled-peer-coaching-for-fatigue-in-systemic-lupus-erythematosus-sle-preliminary-results-from-the-restore-energy-activity-can-help-reach-pilot-randomized-controlled-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mhealth-enabled-peer-coaching-for-fatigue-in-systemic-lupus-erythematosus-sle-preliminary-results-from-the-restore-energy-activity-can-help-reach-pilot-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology